• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.05% Nasdaq Up 0.19%

    More On NVLX

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    PharmaCyte Biotech, Inc. (NVLX)

    -Other OTC
    0.19 Up 0.01(3.12%) Jan 7
    Add to Portfolio
    Prev Close:0.19
    Open:0.19
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.12 - 0.62
    Volume:0
    Avg Vol (3m):1,793,500
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVLX

    Comparison

    Symbol% ChgMkt Cap
    NVLXUp 3.12%N/A
    ECLUp 0.91%32.06B
    NATRUp 1.38%275.87M
    PCGR 0.00%46.31K

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nuvilex, Inc., a biotechnology company, develops treatments for pancreatic cancer, breast cancer, brain cancer, and diabetes through cellulose-based live cell encapsulation technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback